Skip to ContentGo to accessibility page
Microbiology

Multiple Choice

MicrobiologyMultiple Choice

Multiple Choice

1.

For many uses in the laboratory, polyclonal antibodies work well, but for some types of assays, they lack sufficient ________ because they cross-react with inappropriate antigens.

  1. specificity
  2. sensitivity
  3. accuracy
  4. reactivity
2.

How are monoclonal antibodies produced?

  1. Antibody-producing B cells from a mouse are fused with myeloma cells and then the cells are grown in tissue culture.
  2. A mouse is injected with an antigen and then antibodies are harvested from its serum.
  3. They are produced by the human immune system as a natural response to an infection.
  4. They are produced by a mouse’s immune system as a natural response to an infection.
3.

The formation of ________ is a positive result in the VDRL test.

  1. flocculant
  2. precipitin
  3. coagulation
  4. a bright pink color
4.

The titer of a virus neutralization test is the highest dilution of patient serum

  1. in which there is no detectable viral DNA.
  2. in which there is no detectable viral protein.
  3. that completely blocks plaque formation.
  4. that reduces plaque formation by at least 50%.
5.

In the Ouchterlony assay, we see a sharp precipitin arc form between antigen and antiserum. Why does this arc remain visible for a long time?

  1. The antibody molecules are too large to diffuse through the agar.
  2. The precipitin lattice is too large to diffuse through the agar.
  3. Methanol, added once the arc forms, denatures the protein and blocks diffusion.
  4. The antigen molecules are chemically coupled to the gel matrix.
6.

We use antisera to distinguish between various ________ within a species of bacteria.

  1. isotypes
  2. serovars
  3. subspecies
  4. lines
7.

When using antisera to characterize bacteria, we will often link the antibodies to ________ to better visualize the agglutination.

  1. latex beads
  2. red blood cells
  3. other bacteria
  4. white blood cells
8.

The antibody screening test that is done along with pretransfusion blood typing is used to ensure that the recipient

  1. does not have a previously undetected bacterial or viral infection.
  2. is not immunocompromised.
  3. actually does have the blood type stated in the online chart.
  4. is not making antibodies against antigens outside the ABO or Rh systems.
9.

The direct Coombs’ test is designed to detect when people have a disease that causes them to

  1. have an excessively high fever.
  2. quit making antibodies.
  3. make too many red blood cells.
  4. produce antibodies that bind to their own red blood cells.
10.

Viral hemagglutination assays only work with certain types of viruses because

  1. the virus must be able to cross-link red blood cells directly.
  2. the virus must be able to lyse red blood cells.
  3. the virus must not be able to lyse red blood cells.
  4. other viruses are too dangerous to work with in a clinical lab setting.
11.

In an enzyme immunoassay, the enzyme

  1. is bound by the antibody’s antigen-binding site.
  2. is attached to the well of a microtiter plate.
  3. is conjugated to the suspect antigen.
  4. is bound to the constant region of the secondary antibody.
12.

When using an EIA to study microtubules or other structures inside a cell, we first chemically fix the cell and then treat the cells with alcohol. What is the purpose of this alcohol treatment?

  1. It makes holes in the cell membrane large enough for antibodies to pass.
  2. It makes the membrane sticky so antibodies will bind and be taken up by receptor-mediated endocytosis.
  3. It removes negative charges from the membrane, which would otherwise repulse the antibodies.
  4. It prevents nonspecific binding of the antibodies to the cell membrane.
13.

In a lateral-flow pregnancy test, you see a blue band form on the control line and no band form on the test line. This is probably a ________ test for pregnancy.

  1. positive
  2. false-positive
  3. false-negative
  4. negative
14.

When performing an FEIA, the fluorogen replaces the ________ that is used in an EIA.

  1. antigen
  2. chromogenic substrate
  3. enzyme
  4. secondary antibody
15.

Suppose you need to quantify the level of CD8 T cells in the blood of a patient recovering from influenza. You treat a sample of the patient’s white blood cells using a fluorescent mAb against CD8, pass the cells through a flow cytometer, and produce the histogram shown below. The area under the peak to the left (blue) is three times greater than the area of the peak on the right (red). What can you determine from these data?

  1. There are no detectable CD8 cells.
  2. There are three times as many CD4 cells than CD8 cells.
  3. There are three times as many CD8 cells than CD4 cells.
  4. CD8 cells make up about one-fourth of the total number of cells.
16.

In the data described in the previous question, the average fluorescence intensity of cells in the second (red) peak is about ________ that in the first (blue) peak.

  1. three times
  2. 100 times
  3. one-third
  4. 1000 times
17.

In a direct fluorescent antibody test, which of the following would we most likely be looking for using a fluorescently-labeled mAb?

  1. bacteria in a patient sample
  2. bacteria isolated from a patient and grown on agar plates
  3. antiserum from a patient smeared onto a glass slide
  4. antiserum from a patient that had bound to antigen-coated beads
Citation/Attribution
Reuse and redistribution of this content in digital or print format:
  • This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's prior written permission.
  • This book uses the Creative Commons Attribution-NonCommercial-ShareAlike License, which means that you can reuse and modify the material only for noncommercial purposes, must attribute OpenStax, and must distribute any derivative works under the same license.
  • Any commercial printing of this textbook, including using a local or custom printer, must be approved by OpenStax, and proper citation provided.
  • OpenStax-copyrighted images, activities, assessments, and similar components of this book are subject to the same licensing – CC-BY-NC-SA. They can be used for noncommercial purposes with attribution. Commercial use requires permission.
  • Permission requests: Anyone who intends to incorporate this content (including text, images, and other components) into large language models, use it in AI offerings, use it commercially (including in print), and/or has questions about another use case is welcome to complete our reuse request form.
Attribution information
  • If you are redistributing all or part of this book in a noncommercial print format, then you must include on every physical page the following attribution:

    Access for free at https://openstax.org/books/microbiology/pages/1-introduction

  • If you are redistributing all or part of this book in a noncommercial digital format, then for every page that includes OpenStax content, you must license the derivative work under the same CC-BY-NC-SA license as the original, and include on every digital page view the following attribution:

    Access for free at https://openstax.org/books/microbiology/pages/1-introduction

Citation information

The information below includes the information needed to generate citations in most major styles (APA, MLA, etc.); you must reformat and organize the information as needed to fit the requirements of the style. Use the information below to generate a citation. We recommend using a citation tool such as this one.

© Jul 8, 2026 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo, and Rice University name, and Rice University logo trademarks, or wordmarks are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.